32
https://pubmed.ncbi.nlm.nih.gov/38115715
New treatments and technologies for managing diabetes and its complications in primary care are highlighted in this review, with a focus on the benefits of sodium-glucose co-transporter-2 inhibitors and Glucagon-like peptide-receptor agonists 1 for type 2 diabetes management.